Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meetings, 328 [2019-28359]
Download as PDF
<![CDATA[
328
Federal Register / Vol. 85, No. 2 / Friday, January 3, 2020 / Notices
• Development of therapeutics against
severe RSV infection
• Diagnostic biomarker
Competitive Advantages:
• Enhance the innate immune response
to respiratory infection
• Improve clinical trial outcome in
patients with TLR8 mediated RSV
infection
Development Stage:
• Early stage
• In vitro data available
Inventors: Michael Resnick (NIEHS),
Daniel Menendez (NIEHS), Steven
Kleeberger (NIEHS), and Fernando
Polack (Infant Foundation).
Intellectual Property: HHS Reference
No. E–072–2019–0; US Application No.
62/881,656.
Licensing Contact: Vidita Choudhry,
Ph.D.; 301–594–4095; vidita.choudhry@
nih.gov. This notice is made in
accordance with 35 U.S.C. 209 and 37
CFR part 404.
Dated: December 26, 2019.
Vidita Choudhry,
Technology Development Specialist, National
Heart, Lung, and Blood Institute, Office of
Technology Transfer and Development.
[FR Doc. 2019–28358 Filed 1–2–20; 8:45 am]
BILLING CODE 4140–01–P
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Helen Huang, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, NIH, Bethesda, MD 20817,
301–435–8380, helen.huang@nih.gov.
Name of Committee: National Institute of
Child Health and Human Development Initial
Review Group; Function, Integration, and
Rehabilitation Sciences Subcommittee.
Date: February 26, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Helen Huang, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, NIH, Bethesda, MD 20817,
301–435–8380, helen.huang@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: December 27, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–28359 Filed 1–2–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: December 27, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–28357 Filed 1–2–20; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
jbell on DSKJLSW7X2PROD with NOTICES
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference
Call).
Contact Person: Ileana Hancu, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5116,
Bethesda, MD 20817, 301–402–3911,
ileana.hancu@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Secondary Analyses of Existing Datasets in
Heart, Lung and Blood Diseases and Sleep
Disorders.
Date: January 28, 2020.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Heidi B. Friedman, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1012A,
MSC 7770, Bethesda, MD 20892, 301–379–
5632, hfriedman@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
BILLING CODE 4140–01–P
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meetings
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Center for Scientific Review; Notice of
Closed Meetings
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development Initial
Review Group; Reproduction, Andrology,
and Gynecology Subcommittee.
Date: February 21, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Early Phase
Clinical Trials in Imaging and Image-Guided
Interventions (R01 Clinical Trial Required).
Date: January 28, 2020.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
17:29 Jan 02, 2020
Jkt 250001
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
Prospective Grant of an Exclusive
Patent License: Development and
Commercialization of CD19/CD22
Chimeric Antigen Receptor (CAR)
Therapies for the Treatment of B-Cell
Malignancies
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The National Cancer Institute,
an institute of the National Institutes of
Health, Department of Health and
Human Services, is contemplating the
grant of an Exclusive Patent License to
practice the inventions embodied in the
Patents and Patent Applications listed
in the Supplementary Information
section of this Notice to CJ Healthcare,
(‘‘CJ’’), located in Seoul, Republic of
Korea.
DATES: Only written comments and/or
applications for a license which are
received by the National Cancer
SUMMARY:
E:\FR\FM\03JAN1.SGM
03JAN1
]]>Agencies
[Federal Register Volume 85, Number 2 (Friday, January 3, 2020)]
[Notices]
[Page 328]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-28359]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National Institute of Child Health & Human
Development; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Child Health and Human
Development Initial Review Group; Reproduction, Andrology, and
Gynecology Subcommittee.
Date: February 21, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda,
MD 20814.
Contact Person: Helen Huang, Ph.D., Scientific Review Officer,
Scientific Review Branch, Eunice Kennedy Shriver National Institute
of Child Health and Human Development, NIH, Bethesda, MD 20817, 301-
435-8380, [email protected].
Name of Committee: National Institute of Child Health and Human
Development Initial Review Group; Function, Integration, and
Rehabilitation Sciences Subcommittee.
Date: February 26, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda,
MD 20814.
Contact Person: Helen Huang, Ph.D., Scientific Review Officer,
Scientific Review Branch, Eunice Kennedy Shriver National Institute
of Child Health and Human Development, NIH, Bethesda, MD 20817, 301-
435-8380, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.864,
Population Research; 93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation Research; 93.209,
Contraception and Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: December 27, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-28359 Filed 1-2-20; 8:45 am]
BILLING CODE 4140-01-P
